HPS Pharmacies wish to give notice that Roche is experiencing a supply interruption for Actemra® as follows:
Actemra® IV 200mg is currently affected by this supply interruption. It is also anticipated that supplies of Actemra® IV 400mg vials and Actemra® 162mg/0.9mL pre-filled syringes will be affected by August 2021.
This is a global supply interruption related to increased demand as a result of the COVID-19 pandemic. HPS Pharmacies will provide further information on expected return dates when those details are available.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Roche on (02) 9454 9000, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates